CYP 2 D 6 ALLELE POLYMORPHISM : RISK FACTOR FOR PARKINSON DISEASE ?

@inproceedings{Kraus2013CYP2D,
  title={CYP 2 D 6 ALLELE POLYMORPHISM : RISK FACTOR FOR PARKINSON DISEASE ?},
  author={J{\"o}rg Kraus and Johann Sellner and Katrin Oppermann and Wolfgang Koczi and Eva-Maria Duerr and Peter Hol T Er and Georg Pilz and Wolfgang Hitzl and Shahrzad Afazel and Elisabeth Haschke-Becher and Eugen Trinka and Andrea Harrer},
  year={2013}
}
Introduction/Objectives: To analyse the infl uence of shortand long-term glatiramer acetate (GA) treatment on expression patterns of cell surfacebound adhesion molecules (AM) on peripheral blood mononuclear cells (PBMC) from patients with relapsing remitting multiple sclerosis (RRMS). BACKGROUND: GA is baseline therapy for the treatment of RRMS. It is known to reduce relapse frequencies and to delay disease progression but the exact mechanisms of action remain elusive. Here, we investigate AM… CONTINUE READING